Immunotherapy for the Management of Advanced Melanoma: The Next Steps

被引:12
|
作者
Zikich, Dragoslav [1 ]
Schachter, Jacob [1 ]
Besser, Michal J. [1 ,2 ]
机构
[1] Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel
关键词
TUMOR-INFILTRATING LYMPHOCYTES; ADOPTIVE CELL TRANSFER; METASTATIC MELANOMA; T-CELLS; INTERLEUKIN-2; THERAPY; MALIGNANT-MELANOMA; ANTITUMOR IMMUNITY; CANCER REGRESSION; REGULATORY T; NK CELLS;
D O I
10.1007/s40257-013-0013-0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Melanoma is an immunogenic tumor that can induce a natural immune response. A number of immunotherapy-based approaches have been developed over the past decades, and certain degrees of effectiveness were achieved by the use of cytokines, adoptive cell transfer and T-cell immune modulators. Currently, interleukin-2 and the immune stimulatory antibody, ipilimumab, are the only two approved immunotherapies for metastatic melanoma, but various new therapies are in promising developmental stages. This comprehensive review will discuss the latest achievements of immunotherapy and emerging directions for the management of advanced melanoma.
引用
收藏
页码:261 / 272
页数:12
相关论文
共 50 条
  • [41] Improvement in survival by activated immunotherapy in advanced melanoma
    Almubarak, Mohammed
    Abraham, Jame
    [J]. IMMUNOTHERAPY, 2012, 4 (05) : 473 - 473
  • [42] The next steps in improving the outcomes of advanced ovarian cancer
    Openshaw, Mark R.
    Fotopoulou, Christina
    Blagden, Sarah
    Gabra, Hani
    [J]. WOMENS HEALTH, 2015, 11 (03) : 355 - 367
  • [43] Immunotherapy in the management of melanoma: current status
    Alston, Dylan
    Brewer, Jerry D.
    [J]. IMMUNOTARGETS AND THERAPY, 2013, 2 : 1 - 10
  • [44] MANAGEMENT SIMULATIONS - NEXT STEPS IN BUSINESS SCHOOLS
    DONEY, LD
    [J]. JOURNAL OF EDUCATIONAL DATA PROCESSING, 1971, 7 (06): : 23 - &
  • [45] Next Steps in Business and Management Education Scholarship
    Asarta, Carlos J.
    Bento, Regina F.
    Ferrara, Zachary
    Fornaciari, Charles J.
    Hwang, Alvin
    [J]. JOURNAL OF MANAGEMENT EDUCATION, 2020, 44 (05) : 622 - 634
  • [46] TAKING THE NEXT STEPS - THE CHANGING MANAGEMENT OF GOVERNMENT
    FLYNN, A
    GREY, A
    JENKINS, WI
    [J]. PARLIAMENTARY AFFAIRS, 1990, 43 (02) : 159 - 178
  • [47] Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
    Fujimura, Taku
    Muto, Yusuke
    Asano, Yoshihide
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [48] Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy
    Augustin, Ryan C.
    Leone, Robert D.
    Naing, Aung
    Fong, Lawrence
    Bao, Riyue
    Luke, Jason J.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [49] Combination Checkpoint Blockade - Taking Melanoma Immunotherapy to the Next Level
    Riley, James L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02): : 187 - 189
  • [50] Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
    Rohatgi, Anjali
    Kirkwood, John M.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11